Literature DB >> 26629876

Free Superoxide is an Intermediate in the Production of H2O2 by Copper(I)-Aβ Peptide and O2.

Karine Reybier1,2, Sara Ayala3,4, Bruno Alies3,4, João V Rodrigues5,6, Susana Bustos Rodriguez3,4, Giovanni La Penna7, Fabrice Collin8,9,3,4, Cláudio M Gomes5,10, Christelle Hureau3,4, Peter Faller11,12,13.   

Abstract

Oxidative stress is considered as an important factor and an early event in the etiology of Alzheimer's disease (AD). Cu bound to the peptide amyloid-β (Aβ) is found in AD brains, and Cu-Aβ could contribute to this oxidative stress, as it is able to produce in vitro H2O2 and HO˙ in the presence of oxygen and biological reducing agents such as ascorbate. The mechanism of Cu-Aβ-catalyzed H2O2 production is however not known, although it was proposed that H2O2 is directly formed from O2 via a 2-electron process. Here, we implement an electrochemical setup and use the specificity of superoxide dismutase-1 (SOD1) to show, for the first time, that H2O2 production by Cu-Aβ in the presence of ascorbate occurs mainly via a free O2˙(-) intermediate. This finding radically changes the view on the catalytic mechanism of H2O2 production by Cu-Aβ, and opens the possibility that Cu-Aβ-catalyzed O2˙(-) contributes to oxidative stress in AD, and hence may be of interest.
© 2016 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.

Entities:  

Keywords:  Alzheimer's disease; amyloid peptide; bioinorganic chemistry; copper; reactive oxygen species

Mesh:

Substances:

Year:  2015        PMID: 26629876     DOI: 10.1002/anie.201508597

Source DB:  PubMed          Journal:  Angew Chem Int Ed Engl        ISSN: 1433-7851            Impact factor:   15.336


  19 in total

Review 1.  Polyphenols as Potential Metal Chelation Compounds Against Alzheimer's Disease.

Authors:  Johant Lakey-Beitia; Andrea M Burillo; Giovanni La Penna; Muralidhar L Hegde; K S Rao
Journal:  J Alzheimers Dis       Date:  2021       Impact factor: 4.472

Review 2.  All roads lead to Rome - a review of the potential mechanisms by which exerkines exhibit neuroprotective effects in Alzheimer's disease.

Authors:  Yi-Yao Liang; Li-Dan Zhang; Xi Luo; Li-Li Wu; Zhao-Wei Chen; Guang-Hao Wei; Kai-Qing Zhang; Ze-An Du; Ren-Zhi Li; Kwok-Fai So; Ang Li
Journal:  Neural Regen Res       Date:  2022-06       Impact factor: 5.135

3.  Cu and Zn coordination to amyloid peptides: From fascinating chemistry to debated pathological relevance.

Authors:  Elena Atrián-Blasco; Paulina Gonzalez; Alice Santoro; Bruno Alies; Peter Faller; Christelle Hureau
Journal:  Coord Chem Rev       Date:  2018-09-15       Impact factor: 22.315

4.  Metal-catalyzed oxidation of Aβ and the resulting reorganization of Cu binding sites promote ROS production.

Authors:  Clémence Cheignon; Peter Faller; Denis Testemale; Christelle Hureau; Fabrice Collin
Journal:  Metallomics       Date:  2016-10-01       Impact factor: 4.526

Review 5.  Mutual interference of Cu and Zn ions in Alzheimer's disease: perspectives at the molecular level.

Authors:  Elena Atrián-Blasco; Amandine Conte-Daban; Christelle Hureau
Journal:  Dalton Trans       Date:  2017-09-22       Impact factor: 4.390

Review 6.  The Case for Abandoning Therapeutic Chelation of Copper Ions in Alzheimer's Disease.

Authors:  Simon C Drew
Journal:  Front Neurosci       Date:  2017-06-02       Impact factor: 4.677

Review 7.  Oxidative stress and the amyloid beta peptide in Alzheimer's disease.

Authors:  C Cheignon; M Tomas; D Bonnefont-Rousselot; P Faller; C Hureau; F Collin
Journal:  Redox Biol       Date:  2017-10-18       Impact factor: 11.799

8.  Cu(II) binding to various forms of amyloid-β peptides. Are they friends or foes?

Authors:  Valentina Borghesani; Bruno Alies; Christelle Hureau
Journal:  Eur J Inorg Chem       Date:  2018-01-10       Impact factor: 2.524

Review 9.  Metals and Neuronal Metal Binding Proteins Implicated in Alzheimer's Disease.

Authors:  Joana S Cristóvão; Renata Santos; Cláudio M Gomes
Journal:  Oxid Med Cell Longev       Date:  2016-01-10       Impact factor: 6.543

10.  Multi-target-directed phenol-triazole ligands as therapeutic agents for Alzheimer's disease.

Authors:  Michael R Jones; Emilie Mathieu; Christine Dyrager; Simon Faissner; Zavier Vaillancourt; Kyle J Korshavn; Mi Hee Lim; Ayyalusamy Ramamoorthy; V Wee Yong; Shigeki Tsutsui; Peter K Stys; Tim Storr
Journal:  Chem Sci       Date:  2017-06-05       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.